R. Idilman Et Al. , "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program," International Liver Congress (ILC) , vol.68, Paris, France, 2018
Idilman, R. Et Al. 2018. Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program. International Liver Congress (ILC) , (Paris, France).
Idilman, R., Demir, M., Aladag, M., Kaymakoglu, S., Erol, C., Cavus, B., ... Iliaz, R.(2018). Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program . International Liver Congress (ILC), Paris, France
Idilman, R. Et Al. "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program," International Liver Congress (ILC), Paris, France, 2018
Idilman, R. Et Al. "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program." International Liver Congress (ILC) , Paris, France, 2018
Idilman, R. Et Al. (2018) . "Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program." International Liver Congress (ILC) , Paris, France.
@conferencepaper{conferencepaper, author={R. Idilman Et Al. }, title={Recurrence and occurrence of hepatocellular carcinoma following ledipasvir and sofosbuvir treatment for chronic hepatitis C in patients with advanced liver disease: Turkish multi-center early access program}, congress name={International Liver Congress (ILC)}, city={Paris}, country={France}, year={2018}}